Health In Tech Q3 Earnings Forecast Reduced by Maxim Group

Key Points

• Maxim Group cut its Q3 2026 EPS forecast for Health In Tech to a loss of $0.10 per share from a prior estimate of $0.04, while maintaining a Buy rating and $3.00 price target.
• Analyst sentiment is mixed: Weiss Ratings reiterated a Sell rating, but MarketBeat reports an overall Moderate Buy consensus with a $3.50 target price.
• Health In Tech’s shares opened at $0.82, near the lower end of their $0.65–$4.02 52-week range; the company recently reported a quarterly loss of $0.04 per share on $8.06 million in revenue, missing the EPS consensus.

Health In Tech, Inc. (NASDAQ:HIT - Free Report) - Stock analysts at Maxim Group decreased their Q3 2026 earnings estimates for shares of Health In Tech in a research report issued to clients and investors on Friday, October 2nd. Maxim Group analyst A. Klee now anticipates that the company will earn ($0.10) per share for the quarter, down from their previous estimate of ($0.04). Maxim Group currently has a "Buy" rating and a $3.00 price target on the stock. Maxim Group also issued estimates for Health In Tech's Q4 2026 earnings at ($0.14) EPS, FY2026 earnings at ($0.31) EPS, Q1 2027 earnings at ($0.05) EPS, Q2 2027 earnings at ($0.06) EPS, Q3 2027 earnings at ($0.06) EPS, Q4 2027 earnings at ($0.09) EPS and FY2027 earnings at ($0.26) EPS.

Separately, Weiss Ratings reissued a "sell (d)" rating on shares of Health In Tech in a research report on Friday, September 25th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $3.50.

Health In Tech Price Performance

HIT stock opened at $0.82 on Tuesday. The stock has a market capitalization of $53.74 million, a price-to-earnings ratio of -11.71 and a beta of 2.81. The company has a 50-day moving average of $0.97 and a two-hundred day moving average of $1.15. Health In Tech has a 52-week low of $0.65 and a 52-week high of $4.02.

Health In Tech (NASDAQ:HIT - Get Free Report) last announced its earnings results on Thursday, August 13th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01). The company had revenue of $8.06 million for the quarter.

Institutional Trading of Health In Tech

An institutional investor recently bought a new stake in Health In Tech stock. Whetstone Capital Advisors LLC purchased a new position in Health In Tech, Inc. (NASDAQ:HIT - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 1,509,766 shares of the company's stock, valued at approximately $1,525,000. Whetstone Capital Advisors LLC owned about 2.30% of Health In Tech at the end of the most recent reporting period.

About Health In Tech

Health In Tech, Inc NASDAQ: HIT is a U.S.-based insurance technology company that provides a digital platform for the self-funded health insurance market. Its technology is designed to connect employers, insurance brokers, third-party administrators and stop-loss insurance carriers through a streamlined online process.

The company's platform supports activities such as plan quoting, underwriting, enrollment and related policy administration. By digitizing these processes, Health In Tech aims to simplify how self-funded health plans are evaluated, selected and managed, while improving access to information for the organizations and professionals involved.

Health In Tech serves participants in the U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.